Toxic Shock Syndrome (TSS) Caused by Group A Streptococcus: Novel Insights Within the Context of a Familiar Clinical Syndrome

J Korean Med Sci. 2024 May 6;39(17):e154. doi: 10.3346/jkms.2024.39.e154.

Abstract

The emergence of invasive infections attributed to group A Streptococcus (GAS) infections, has resurged since the 1980s. The recent surge in reports of toxic shock syndrome due to GAS in Japan in 2024, while sensationalized in the media, does not represent a novel infectious disease per se, as its diagnosis, treatment, and prevention are already well-established. However, due to signs of increasing incidence since 2011, further research is needed. Health authorities in neighboring countries like The Republic of Korea should not only issue travel advisories but also establish meticulous surveillance systems and initiate epidemiological studies on the genotypic variations of this disease while awaiting various epidemiological research findings from Japan.

Keywords: Streptoccus pyogenes; Toxic Shock Syndrome.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Enterotoxins / genetics
  • Humans
  • Japan
  • Republic of Korea
  • Shock, Septic* / microbiology
  • Streptococcal Infections* / diagnosis
  • Streptococcal Infections* / microbiology
  • Streptococcus pyogenes* / genetics
  • Streptococcus pyogenes* / isolation & purification
  • Superantigens / genetics

Substances

  • Superantigens
  • Anti-Bacterial Agents
  • Enterotoxins